Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)
South Korea
· Delayed Price · Currency is KRW
26,850
0.00 (0.00%)
Dec 20, 2024, 9:00 AM KST
Daihan Pharmaceutical Co.,Ltd. Revenue
Daihan Pharmaceutical Co.,Ltd. had revenue of 54.85B KRW in the quarter ending September 30, 2024, with 7.70% growth. This brings the company's revenue in the last twelve months to 201.97B, up 3.83% year-over-year. In the year 2023, Daihan Pharmaceutical Co.,Ltd. had annual revenue of 195.91B with 6.32% growth.
Revenue (ttm)
201.97B
Revenue Growth
+3.83%
P/S Ratio
0.78
Revenue / Employee
365.23M
Employees
553
Market Cap
157.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 195.91B | 11.64B | 6.32% |
Dec 31, 2022 | 184.27B | 12.80B | 7.47% |
Dec 31, 2021 | 171.46B | 5.38B | 3.24% |
Dec 31, 2020 | 166.08B | -2.68B | -1.59% |
Dec 31, 2019 | 168.76B | 10.04B | 6.33% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition